Search Results 1191-1200 of 16895 for monoclonal antibody
Both chimeric antigen receptor (CAR)-T cell and bispecific antibody (BsAb) as T cell-directed therapies have yielded impressive clinical responses in people ...
the Second International Workshop on Waldenström macroglobulinemia. - At least 2 prior lines of treatment, including an anti-CD20 monoclonal antibody-containing ...
... monoclonal antibody therapy, amatuximab or any of its excipients); Pregnant and/or lactating females are excluded. A negative beta-human chorionic ...
Previous fecal transplant, RBX2660 treatment, receipt of CDI vaccine or treatment with CDI monoclonal antibodies prior to study enrollment. History of ...
... (monoclonal gammopathy of thrombotic/thrombocytopenic significance). ... MemberThe Antibody Society. 2021 - present. FacultyDLMP Research Strategy: Mentoring ...
Complement activation after binding of an IgG autoantibody ... monoclonal IgG that neutralises the complement protein C5--in neuromyelitis optica spectrum ...
STI-3031, a fully human anti-PDL1 recombinant monoclonal Ab, will be supplied by Sorrento. ... antibody do not count). Exclusion Criteria. Any of ... Anti-PD(L)1 ...
Monoclonal Gammopathy and Its Association with ... Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
Patients who are newly diagnosed with lymphoma are offered a combination of chemotherapy and antibody-based treatments. But for those who do not respond to ...
and immunosuppressant monoclonal antibody treatment must be discontinued a minimum of 4 weeks prior to the first dose of pirtobrutinib. In addition, no ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.